Glycerophospholipids

DBCAT001464Pharmacologic class

Derivatives of phosphatidic acid in which the hydrophobic regions are composed of two fatty acids and a polar alcohol is joined to the C-3 position of glycerol through a phosphodiester bond. They are named according... A DrugBank category of 20 drugs. 7 of them are approved.

Also known as: Phosphoglycerides
Drugs: 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine
1,2-Dioleoyl-sn-glycero-3-phospho-L-serine
1,2-Distearoyllecithin
Cadaverine
CHF5633
Choline alfoscerate
Colfosceril palmitate
DL-dimyristoylphosphatidylcholine
DL-dimyristoylphosphatidylglycerol
ETC-588
Iopofosine I-131
L-Dilinoleoyllecithin
Lecithin
Lucinactant
Mifamurtide
Phosphatidyl serine
Phosphatidylethanolamine
Platelet Activating Factor
sn-glycero-3-phosphoethanolamine
VB-201

What you can answer from here — as of August 24, 2016

20DrugsEach linked to its full drug card

Listed above

38Drug targetsEvery drug–target pair in the class, with bond type

61Marketed productsAcross the regions we cover, with dosage forms and routes

8Routes of administrationHow the drugs in this class are given

Which targets do Glycerophospholipids share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account